Published in Gastroenterology on November 01, 2008
Variation in organ quality between liver transplant centers. Am J Transplant (2011) 1.99
Development of organ-specific donor risk indices. Liver Transpl (2012) 1.26
Model for end-stage liver disease: end of the first decade. Clin Liver Dis (2011) 1.20
Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05
Impact of the center on graft failure after liver transplantation. Liver Transpl (2013) 0.98
Experience Since MELD Implementation: How Does the New System Deliver? Int J Hepatol (2012) 0.92
Organ allocation for chronic liver disease: model for end-stage liver disease and beyond. Curr Opin Gastroenterol (2010) 0.92
Model for End-stage Liver Disease. J Clin Exp Hepatol (2012) 0.92
Systematic bias in surgeons' predictions of the donor-specific risk of liver transplant graft failure. Liver Transpl (2013) 0.86
Organ quality and quality of life after liver transplantation. Liver Transpl (2011) 0.82
Prognostic limitations of the Eurotransplant-Donor Risk Index in liver transplantation. J Negat Results Biomed (2013) 0.82
Liver transplantation in the high MELD era: a fair chance for everyone? Langenbecks Arch Surg (2011) 0.81
Rescue policy for discarded liver grafts: a single-centre experience of transplanting livers 'that nobody wants'. HPB (Oxford) (2010) 0.78
Using higher risk organs for liver transplantation: in whom and at what price? Gastroenterology (2008) 0.78
D-MELD risk capping improves post-transplant and overall mortality under markov microsimulation. World J Transplant (2014) 0.77
Decision support for organ offers in liver transplantation. Liver Transpl (2015) 0.75
SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION IN LIVER TRANSPLANT CANDIDATES WITH RENAL DYSFUNCTION: IMPORTANCE OF CREATININE LEVELS, DIALYSIS, AND ORGAN QUALITY IN SURVIVAL. KI Rep (2016) 0.75
Lying to insurance companies: the desire to deceive among physicians and the public. Am J Bioeth (2004) 8.49
Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med (2004) 6.86
American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol (2009) 6.77
Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet (2012) 6.60
Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA (2007) 5.60
Measuring numeracy without a math test: development of the Subjective Numeracy Scale. Med Decis Making (2007) 4.80
The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med (2002) 4.79
Sex differences in attainment of independent funding by career development awardees. Ann Intern Med (2009) 4.62
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med (2012) 4.51
Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med (2003) 3.81
Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med (2012) 3.79
Lessons from the mammography wars. N Engl J Med (2010) 3.68
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials (2010) 3.45
Management of hepatitis B: summary of a clinical research workshop. Hepatology (2007) 3.40
Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology (2010) 3.35
Solid-organ transplantation in HIV-infected patients. N Engl J Med (2002) 3.34
Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology (2009) 3.10
Are bad outcomes from questionable clinical decisions preventable medical errors? A case of cascade iatrogenesis. Ann Intern Med (2002) 3.07
Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med (2007) 3.05
Validation of the Subjective Numeracy Scale: effects of low numeracy on comprehension of risk communications and utility elicitations. Med Decis Making (2007) 2.89
Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care (2003) 2.88
Patients, privacy and trust: patients' willingness to allow researchers to access their medical records. Soc Sci Med (2006) 2.86
Building a better quality measure: are some patients with 'poor quality' actually getting good care? Med Care (2003) 2.85
Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology (2002) 2.79
Accepting critically ill transfer patients: adverse effect on a referral center's outcome and benchmark measures. Ann Intern Med (2003) 2.75
Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med (2004) 2.73
In a mailed physician survey, questionnaire length had a threshold effect on response rate. J Clin Epidemiol (2005) 2.71
Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities. Health Serv Res (2002) 2.68
Gender differences in salary in a recent cohort of early-career physician-researchers. Acad Med (2013) 2.68
Gender differences in the salaries of physician researchers. JAMA (2012) 2.66
Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. J Hepatol (2008) 2.66
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol (2005) 2.63
Helping patients decide: ten steps to better risk communication. J Natl Cancer Inst (2011) 2.61
When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make? J Gen Intern Med (2003) 2.51
Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation (2008) 2.45
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology (2008) 2.44
Reducing the influence of anecdotal reasoning on people's health care decisions: is a picture worth a thousand statistics? Med Decis Making (2005) 2.43
Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med (2015) 2.42
Case management for patients with poorly controlled diabetes: a randomized trial. Am J Med (2004) 2.41
Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. J Hepatol (2010) 2.38
Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology (2003) 2.38
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology (2002) 2.34
Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens. J Gen Intern Med (2005) 2.32
Randomized trial of 5 dollars versus 10 dollars monetary incentives, envelope size, and candy to increase physician response rates to mailed questionnaires. Med Care (2002) 2.30
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. J Hepatol (2005) 2.26
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl (2002) 2.25
Predictors of physician career satisfaction, work-life balance, and burnout. Obstet Gynecol (2007) 2.25
An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ (2010) 2.22
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol (2003) 2.18
Does competition for transplantable hearts encourage 'gaming' of the waiting list? Health Aff (Millwood) (2004) 2.15
Uninsured adults presenting to US emergency departments: assumptions vs data. JAMA (2008) 2.15
Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology (2004) 2.09
Noninvasive monitoring of patients with chronic hepatitis C. Hepatology (2002) 2.08
Harnessing the power of default options to improve health care. N Engl J Med (2007) 2.07
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial. Hepatology (2006) 2.06
Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus. Arch Intern Med (2010) 2.06
Making numbers matter: present and future research in risk communication. Am J Health Behav (2007) 2.05
Virologic response and resistance to adefovir in patients with chronic hepatitis B. J Hepatol (2005) 2.04
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol (2007) 2.00
Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Hepatology (2011) 1.98
Why It's Not Time for Health Care Rationing. Hastings Cent Rep (2015) 1.97
Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med (2011) 1.92
HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology (2002) 1.88
Re-weighting the model for end-stage liver disease score components. Gastroenterology (2008) 1.83
Clinical significance of hepatitis B virus genotypes. Hepatology (2002) 1.82
Similarities and differences in the career trajectories of male and female career development award recipients. Acad Med (2011) 1.81
Seasonal variation in surgical outcomes as measured by the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP). Ann Surg (2007) 1.81
How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services? Diabetes Care (2003) 1.81
Does physician communication influence older patients' diabetes self-management and glycemic control? Results from the Health and Retirement Study (HRS). J Gerontol A Biol Sci Med Sci (2007) 1.80
Performance measurement in search of a path. N Engl J Med (2007) 1.78
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut (2010) 1.78
Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology (2006) 1.76
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C. Gastroenterology (2006) 1.76
Caregiving behavior is associated with decreased mortality risk. Psychol Sci (2009) 1.76
Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. Liver Transpl (2008) 1.72
The impact of diabetes on workforce participation: results from a national household sample. Health Serv Res (2004) 1.70
The role of physicians' recommendations in medical treatment decisions. Med Decis Making (2002) 1.70
Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Circulation (2007) 1.68
Specialty care and the patient-centered medical home. Med Care (2011) 1.68
Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg (2006) 1.66
Alternate methods of framing information about medication side effects: incremental risk versus total risk of occurrence. J Health Commun (2008) 1.65
Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation. Liver Transpl (2007) 1.64
Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care (2005) 1.64
What causes pregnancy loss? Preexisting mental illness as an independent risk factor. Gen Hosp Psychiatry (2007) 1.63
Incremental costs of post-liver transplantation complications. J Am Coll Surg (2007) 1.63
The DECISIONS study: a nationwide survey of United States adults regarding 9 common medical decisions. Med Decis Making (2010) 1.63
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials (2014) 1.62
All-or-nothing treatment targets make bad performance measures. Am J Manag Care (2007) 1.61
Marriage and cohabitation outcomes after pregnancy loss. Pediatrics (2010) 1.61
Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma. Liver Transpl (2007) 1.61
Mentor networks in academic medicine: moving beyond a dyadic conception of mentoring for junior faculty researchers. Acad Med (2013) 1.60
Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs. Patient Educ Couns (2008) 1.60
New diabetes HEDIS blood pressure quality measure: potential for overtreatment. Am J Manag Care (2010) 1.60
Contact isolation in surgical patients: a barrier to care? Surgery (2003) 1.60
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Patient comprehension of emergency department care and instructions: are patients aware of when they do not understand? Ann Emerg Med (2008) 1.57
Indications for therapy in hepatitis B. Hepatology (2009) 1.57
Rethinking the objectives of decision aids: a call for conceptual clarity. Med Decis Making (2007) 1.54
When there is too much to do: how practicing physicians prioritize among recommended interventions. J Gen Intern Med (2004) 1.53